[Can lorazepam be distinguished from other short-acting benzodiazepines in regard to brain damage and withdrawal symptoms?]
Ned Tijdschr Geneeskd
.
1981 Jan 24;125(4):156.
[Article in Dutch]
Author
L J van Hiele
PMID:
6111030
No abstract available
Publication types
Letter
MeSH terms
Anti-Anxiety Agents / adverse effects*
Humans
Lorazepam / adverse effects*
Substance Withdrawal Syndrome*
Substance-Related Disorders*
Substances
Anti-Anxiety Agents
Lorazepam